Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120583602 | 12058360 | 2 | F | 20160708 | 20160210 | 20160714 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2016-009693 | BRISTOL MYERS SQUIBB | 22.00 | YR | M | Y | 0.00000 | 20160714 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 120583602 | 12058360 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Oral | 2 MG, QD | Y | 21436 | 2 | MG | QD | ||||||
| 120583602 | 12058360 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Y | 21436 | |||||||||||
| 120583602 | 12058360 | 3 | C | BREXPIPRAZOLE | BREXPIPRAZOLE | 1 | Oral | 1 MG, QD; DOSE WAS INCREASED TO 3MG | 0 | 1 | MG | QD | |||||||
| 120583602 | 12058360 | 4 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | UNK, PRN | U | 0 | |||||||||
| 120583602 | 12058360 | 5 | C | EFFEXOR | VENLAFAXINE HYDROCHLORIDE | 1 | Unknown | 300 MG, QD | U | 0 | 300 | MG | QD | ||||||
| 120583602 | 12058360 | 6 | C | XANAX | ALPRAZOLAM | 1 | Unknown | U | 0 | ||||||||||
| 120583602 | 12058360 | 7 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | U | 0 | ||||||||||
| 120583602 | 12058360 | 8 | C | VITAMIN D /00107901/ | ERGOCALCIFEROL | 1 | Unknown | 6000 UNIT, UNK | U | 0 | 6000 | DF | |||||||
| 120583602 | 12058360 | 9 | C | PREVACID | LANSOPRAZOLE | 1 | Unknown | U | 0 | ||||||||||
| 120583602 | 12058360 | 10 | C | VYVANSE | LISDEXAMFETAMINE DIMESYLATE | 1 | Unknown | 40 MG, BID | U | 0 | 40 | MG | BID | ||||||
| 120583602 | 12058360 | 11 | C | ZOCOR | SIMVASTATIN | 1 | Unknown | U | 0 | ||||||||||
| 120583602 | 12058360 | 12 | C | ATENOLOL. | ATENOLOL | 1 | Unknown | 50 MG, BID | U | 0 | 50 | MG | BID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 120583602 | 12058360 | 1 | Anxiety |
| 120583602 | 12058360 | 2 | Major depression |
| 120583602 | 12058360 | 3 | Anxiety |
| 120583602 | 12058360 | 4 | Product used for unknown indication |
| 120583602 | 12058360 | 6 | Product used for unknown indication |
| 120583602 | 12058360 | 7 | Product used for unknown indication |
| 120583602 | 12058360 | 8 | Product used for unknown indication |
| 120583602 | 12058360 | 9 | Gastrooesophageal reflux disease |
| 120583602 | 12058360 | 10 | Anxiety |
| 120583602 | 12058360 | 11 | Anxiety |
| 120583602 | 12058360 | 12 | Anxiety |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 120583602 | 12058360 | Headache | |
| 120583602 | 12058360 | Hunger | |
| 120583602 | 12058360 | Off label use | |
| 120583602 | 12058360 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 120583602 | 12058360 | 1 | 2013 | 20160708 | 0 |